Radiation boosts immunotherapy in advanced lung cancer trial
NCT ID NCT03176173
First seen Nov 05, 2025 · Last updated May 11, 2026 · Updated 19 times
Summary
This study tested whether adding high-dose radiation to standard immunotherapy can help control advanced non-small cell lung cancer that has spread. 45 adults with stage IV disease who were already on immunotherapy received targeted radiation to their tumors. The goal was to improve response rates and delay cancer progression. Results showed that the combination led to tumor shrinkage in many patients and improved progression-free survival at 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University, School of Medicine
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.